Cargando…
Cancer-related FGFR2 overexpression and gene amplification in Japanese patients with gastric cancer
OBJECTIVE: Fibroblast growth factor receptor 2 (FGFR2) has been proposed as a novel druggable target in unresectable gastric cancer. FGFR2 alteration has been reported as associated with poor prognosis even in patients with gastric cancer who received systemic chemotherapy. This study aimed to evalu...
Autores principales: | Minashi, Keiko, Yamada, Takeshi, Hosaka, Hisashi, Amagai, Kenji, Shimizu, Yoshiaki, Kiyozaki, Hirokazu, Sato, Mikio, Soeda, Atsuko, Endo, Shinji, Ishida, Hiroyasu, Kamoshida, Toshiro, Sakai, Yoshinori, Shitara, Kohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491535/ https://www.ncbi.nlm.nih.gov/pubmed/34258618 http://dx.doi.org/10.1093/jjco/hyab104 |
Ejemplares similares
-
Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer
por: Jogo, Tomoko, et al.
Publicado: (2021) -
Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer
por: Yamaguchi, Kensei, et al.
Publicado: (2022) -
FGFR2 gene amplification and clinicopathological features in gastric cancer
por: Matsumoto, K, et al.
Publicado: (2012) -
Incidence of FGFR2 Amplification and FGFR2 Fusion in Patients with Metastatic Cancer Using Clinical Sequencing
por: Hyung, Sujin, et al.
Publicado: (2022) -
Cecal perforation with an ascending colon cancer caused by upper gastrointestinal endoscopy
por: Miyatani, Hiroyuki, et al.
Publicado: (2009)